Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesCTUnderstanding CT flow artifacts is key to better disease diagnosisUnderstanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.Molecular ImagingDual-tracer PET/CT shows promise in liver cancer patientsWomens ImagingStudies lacking for trans breast cancer screening trendsArtificial IntelligenceChatGPT performs poorly on ACR exam for residentsSponsor ContentMy BreastAI Suite by GE HealthCare